Related Experiment Video
Updated: Jan 18, 2026

Fabrication of Tongue Extracellular Matrix and Reconstitution of Tongue Squamous Cell Carcinoma In Vitro
Published on: June 20, 2018
FOXA1 Transcriptional Repression of PLSCR1 Inhibits Tongue Squamous Cell Carcinoma Progression
Jinxin Wang1, Cong Zhang1, Junrong Wang1
1Department of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, P.R. China.
Abstract:
Tongue squamous cell carcinoma (TSCC) is a major subtype of head and neck cancer with limited treatment regimens. This paper examined phospholipid scramblase 1 (PLSCR1) and forkhead box protein A1 (FOXA1) expression patterns and function in TSCC progression. Abnormally high expression of PLSCR1 was screened by the GEO datasets, and PLSCR1 expression in TSCC cells was verified. The upstream mechanism of abnormally elevated PLSCR1 was investigated by bioinformatics analysis, and FOXA1 expression in TSCC cells was detected. The interaction between FOXA1 and the PLSCR1 promoter in cells was detected by chromatin immunoprecipitation and dual-luciferase assay. The TSCC cell malignant phenotype was examined after different lentiviral vector treatments. Xenograft tumors were induced in mice to verify the mechanism. PLSCR1 was highly expressed in TSCC, while FOXA1 was downregulated. PLSCR1 knockdown inhibited TSCC cell proliferation, migration, and invasion, and upregulated apoptosis. Ectopic expression of FOXA1 repressed the malignant behaviors of TSCC cells. FOXA1 was enriched in the PLSCR1 promoter in TSCC cells, and FOXA1 transcriptionally inhibited PLSCR1 expression. In rescue experiments, overexpression of FOXA1 inhibited TSCC progression, and this could be reversed by overexpression of PLSCR1. Overall, FOXA1 prevents TSCC progression through transcriptional repression of PLSCR1.
Insights
Forkhead box protein A1 (FOXA1) suppresses tongue squamous cell carcinoma (TSCC) by inhibiting phospholipid scramblase 1 (PLSCR1) expression. This discovery offers new therapeutic targets for head and neck cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Tongue squamous cell carcinoma (TSCC) presents limited therapeutic options.
- Phospholipid scramblase 1 (PLSCR1) and Forkhead box protein A1 (FOXA1) roles in TSCC are not fully understood.
Purpose of the Study:
- To investigate the expression patterns and functional relationship between PLSCR1 and FOXA1 in TSCC progression.
- To elucidate the regulatory mechanism of PLSCR1 by FOXA1 in TSCC.
Main Methods:
- GEO dataset analysis for PLSCR1 screening.
- Bioinformatics analysis for upstream mechanisms.
- Chromatin immunoprecipitation and dual-luciferase assays to detect FOXA1-PLSCR1 promoter interaction.
- In vitro cell assays and in vivo xenograft models to assess TSCC malignant phenotypes.
Main Results:
- PLSCR1 was significantly upregulated in TSCC, while FOXA1 was downregulated.
- PLSCR1 knockdown suppressed TSCC cell proliferation, migration, and invasion, and increased apoptosis.
- FOXA1 overexpression repressed TSCC malignant behaviors.
- FOXA1 directly binds to the PLSCR1 promoter and transcriptionally inhibits its expression.
- FOXA1's tumor-suppressive role was confirmed in rescue experiments.
Conclusions:
- FOXA1 acts as a tumor suppressor in TSCC by transcriptionally inhibiting PLSCR1.
- Targeting the FOXA1-PLSCR1 axis may offer a novel therapeutic strategy for TSCC.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Co-activators and Co-repressors
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Inheritance of Chromatin Structures
Regulation of Expression Occurs at Multiple Steps

